Patterson Companies (PDCO) to Release Quarterly Earnings on Wednesday

Patterson Companies (NASDAQ:PDCO) is projected to issue its quarterly earnings data before the market opens on Wednesday, February 26th. Analysts expect the company to announce earnings of $0.62 per share and revenue of $1.63 billion for the quarter. Patterson Companies has set its FY25 guidance at $2.25-$2.35 EPS and its FY 2025 guidance at 2.250-2.350 EPS.

Patterson Companies (NASDAQ:PDCO) last posted its quarterly earnings data on Thursday, December 5th. The company reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.02). The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.65 billion. Patterson Companies had a return on equity of 19.77% and a net margin of 2.37%. The firm’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.50 earnings per share. On average, analysts expect Patterson Companies to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Patterson Companies Price Performance

PDCO stock opened at $31.07 on Tuesday. The business has a 50-day moving average of $30.93 and a 200-day moving average of $25.22. Patterson Companies has a fifty-two week low of $19.45 and a fifty-two week high of $31.79. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.37 and a quick ratio of 0.76. The stock has a market capitalization of $2.74 billion, a P/E ratio of 18.17, a P/E/G ratio of 2.71 and a beta of 0.90.

Wall Street Analyst Weigh In

Several research analysts recently commented on PDCO shares. Leerink Partnrs cut Patterson Companies from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Robert W. Baird increased their price target on Patterson Companies from $25.00 to $31.00 and gave the company a “neutral” rating in a research report on Thursday, December 12th. Piper Sandler reduced their price target on Patterson Companies from $26.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, December 6th. Morgan Stanley increased their price target on Patterson Companies from $27.00 to $31.35 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Leerink Partners reissued a “market perform” rating and set a $31.35 price target (up from $29.00) on shares of Patterson Companies in a research report on Wednesday, December 11th. Eleven research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Patterson Companies currently has a consensus rating of “Hold” and an average target price of $26.57.

Insider Buying and Selling at Patterson Companies

In other Patterson Companies news, CEO Donald Zurbay sold 1,962 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $23.08, for a total value of $45,282.96. Following the sale, the chief executive officer now owns 222,736 shares in the company, valued at $5,140,746.88. This represents a 0.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.90% of the company’s stock.

About Patterson Companies

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.